Mark Rosenberg

Mark Rosenberg is a health policy expert and the CEO of JustMedicine, Inc., a non-profit organization dedicated to developing creative solutions to pharmaceutical market inefficiencies that decrease consumer welfare.

Preventing Drug Shortages and Saving Lives: The Role of Quality and Reliability Standards

Prescription drug shortages have become more common in recent years, interrupting usual medical care and increasing patient risk and system costs, but...

The Generic Pharmaceutical Market Needs Competition. Non-Profits Can Provide It

JustMedicine is a non-profit that aims to introduce competition into the generic drug market by sponsoring generic entrants. The organization’s CEO explains why non-profit...

Latest news

How to Make the Market for Real Estate Agents More Competitive

Delinking buyer and seller commissions will make markets for real estate agent services more competitive, allowing buyers and sellers to negotiate commissions...

Dislocation, Dislocation, Dislocation: Covid, the Retail Crisis, and REITs

In an excerpt from his new book Retail Recovery, retail expert and author Mark Pilkington explores the impact of the sector's decline...

Addressing Climate Change Must Begin with Verifiable Carbon Accounting

Robert Kaplan and Karthik Ramanna propose a new approach for verifiable accounting on indirect corporate emissions that would apply to all corporations,...

The FTC Was Correct to Withdraw the Vertical Merger Guidelines

The 2020 Vertical Merger Guidelines, now withdrawn by the FTC, did not represent sound merger policy, argues Steven Salop; rather, they were...

The Chicago Planning Program and the Interdisciplinary Tradition of the Chicago School

The Chicago Planning Program, an interdisciplinary program that operated at the University of Chicago between 1947 and 1956, is an often-neglected part...

Why a “Whole-of-Government” Approach is the Solution to Antitrust’s Current Labor Problem

For the majority of America’s regulatory history, the problem of employer monopsony was understood as a competition policy issue that required direct...

Antitrust Law’s Unwritten Rules of Unfair Competition

Does the Sherman Act actually “protect competition, not competitors”? An examination of the case law reveals a more nuanced picture, in which...